Precigen (PGEN) said Friday that it has signed a securities purchase agreement to sell its 8% series A convertible perpetual preferred stock via a private placement for estimated gross proceeds of $79 million.
The company said investors will have the right to exercise warrants to purchase approximately 52.7 million shares of its stock at $0.75 per warrant. It expects the offering to close on or before Monday.
Precigen said the net proceeds from the offering will be used for working capital and general corporate purposes. It also said it expects the financing, along with its cash on hand, will extend its cash runway "well into 2026."
Shares of Precigen were down 2.2% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.